Insights from Industry Innovators
Carey Powers caught up with five innovative companies at this years OIS XIV in San Diego, to discuss the latest advancements in ophthalmology on the OIS podcast.
Topics included touchless laser therapy for presbyopia, extending the duration of intravitreal treatments, next-generation tear fluid testing, and new imaging methodologies for vitreoretinal conditions. Guests include:
🔹Alex Lopez, Chief Commercial Officer – Ace Vision Group
🔹Houman Hamadi, MD, PhD, Co-Founder & Chief Medical Officer – Optigo Biotherapeutics
🔹Leanne Lavriola, DO, MBA, President & CEO – InnSight Technology
🔹Nir Katchinskiy, PhD, CEO & Co-Founder – PulseMedica
Resources:
Ace Vision Group: https://staging.acevision.pinedev.in.ua/
Optigo Biotherapeutics: https://www.optigobio.com/
InnSight Technology: https://www.innsightech.com/
PulseMedica: https://www.pulsemedica.com/
Explore More Articles
Ace Vision Group Names Rob Kissling, MD, as Chief Medical Officer
Ace Vision Group announced that it has named Rob Kissling, MD, as Chief Medical Officer. Dr. Kissling has more than 20 years of experience integrating clinical development, medical strategy, and business planning to develop and commercialize devices and medicines for ophthalmology. His tenure has included companies such as Pharmacia, Pfizer, and Novartis. Most recently, he …
read moreLaser scleral microporation may solve biomechanical problem of presbyopia
CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Alex Lopez of Ace Vision Group discusses laser scleral microporation for presbyopia. Lopez said the GenII device can potentially deliver improved near vision without compromising distance vision in patients with presbyopia. The company plans to do a study in the United States in 2026, potentially leading to commercial availability in …
read moreThe Answer for Aging Eyes?
The accommodation mechanism is the core moving “engine” of the eye – responsible for dynamic range of visual focus, as well as hydrodynamic equilibrium and circulatory functions. Doesn’t it seem likely that there would be potential ocular health benefits in rejuvenating rigid ocular tissues? Today, there still is no authentic viable therapeutic to rejuvenate ocular …
read more